Last updated on August 2017

Changes in Body Composition After EPA Supplementation in Head and Neck Patients


Brief description of study

Evaluates the effect of EPA supplementation in terms of muscle mass in patients with squamous cell carcinoma of the head and neck locally advanced

Detailed Study Description

This study is designed to evaluate the effect of EPA supplementation on muscle mass in patients with squamous cell carcinoma of the head and neck locally advanced (stage III-IVb) to assess that supplementation with EPA can maintain muscle mass along the oncologic treatment. Other aims are to evaluate the nutritional status, acute and chronic toxicities related with the loss of muscle mass and the impact of the EPA supplementation on overall and disease-free survival.

Clinical Study Identifier: NCT02715596

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Lorena Arribas

Institut Catala d'Oncologia- L'Hospitalet
L´hospitalet de Llobregat, Spain
  Connect »